BAMBUDIL
Brand:
BAMBUDIL
Manufacturer:
CIPLA
Manufacturer Details
CIPLA
Compositions:
Bambuterol hcl 10mg/20mg tablets,
|
Strength
|
Rate
|
Packing Style
|
|
10mg
|
36.80
|
10s tablets
|
|
20mg
|
64.30
|
10s tablets
|
List of Related Indications:
- Asthma
- Bronchospasm in asthma
List Of Drugs:
- Bambuterol hcl- Bronchodilator
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
Risk of hypokalemia increased by co-admin of corticoseroids, diuretics or xanthine prolong action of drugs eg. suxamethonium
Indication:
Reversible airway obstruction
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Bambuterol Bronchdilator 13-12-1999
Adverse Reaction:
Fine tremor of skeletal muscles eg hands, palpitations, and muscle cramps, tachycardia, tenseness and peripheral vasodilation
Contra-Indications:
severe hepatic impairment, cirrhosis
Special precautions-
Hyperthyroidism , myocarial insufficiency Arrhythmias, susceptibility to QT- interval prolongation Pregnancy
Dosages/ Overdosage Etc:
Indication-
Reversible airway obstruction
Dosage-
10-20mg once daily at bed time
Pharmacology/ Pharmacokinetics:
Pharmacology:
Bambuterol is stable to presystemic elimination and is concentrated by lung tissue following its absorption from the GIT. Bambuterol is hydrolysed to terbutaline the active Beta adrenergic receptor agonist
Pharmacokinetics:
The mean peak terbutaline concentration at steady state occurs between 3.9 and 6.8 hours. Cmax is higher when the dose is ingested in the evening compared with the morning, but not age related.
Interaction with Food:
Preferably taken shortly before bed time
Pregnancy and lactation:
Use contraindicated Observe caution.
